| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to veterinary science and aims at preventing and treating the porcine respiratory disease complex PRDC. What is declared is using a recombinant protein ORF2 PCV2 or an immunogenic composition containing the recombinant protein ORF2 PCV2, for preparing a therapeutic agent for preventing and treating the porcine respiratory disease complex (PRDC) caused by Mycoplasma hyorhinis and/or a PRDC-associated clinical symptom of a notable increase of a death rate in the middle to late feeding phase caused by PCV2, and at least one another pathogen causing PRDC in animals, wherein one pathogen causing PRDC is specified in a group containing PRRSV, Mycoplasma hyopneumoniae, Bordetella bronchiseptica, swine influenza virus, Actinobacillus pleuropneumoniae, Mycoplasma hyorhinis. Streptococcus suis and/or Pasteurella multocida.EFFECT: invention is high-effective for treating and preventing the porcine respiratory disease complex PRDC.2 dwg, 3 tbl, 3 ex |
